HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$2.46
Day range
$2.29 - $2.51
Year range
$2.08 - $6.20
Market cap
20.31M USD
Avg Volume
107.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 314.00K | — |
Operating expense | 5.55M | -7.50% |
Net income | -15.99M | 64.44% |
Net profit margin | -5.09K | 68.97% |
Earnings per share | — | — |
EBITDA | -4.73M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.43M | -53.82% |
Total assets | 74.89M | -25.18% |
Total liabilities | 49.30M | -18.51% |
Total equity | 25.59M | — |
Shares outstanding | 8.27M | — |
Price to book | 0.99 | — |
Return on assets | -16.16% | — |
Return on capital | -34.17% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.99M | 64.44% |
Cash from operations | -4.56M | 52.72% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.35M | 58.76% |
Free cash flow | 1.63M | — |
About
Founded
2009
Headquarters
Website
Employees
45